Clincosm LogoSign in Get a demo

advanced melanoma

Showing 26 - 50 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Melanoma Trial (DCB-BO1301)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Mar 17, 2022

Advanced Melanoma Trial in Beijing (JS001+Imatinib mesylate)

Recruiting
  • Advanced Melanoma
  • JS001+Imatinib mesylate
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 2, 2022

Advanced Melanoma, Hepatitis B, Hepatitis C Trial in Taipei 105

Completed
  • Advanced Melanoma
  • +2 more
    • Taipei 105, Taiwan
      Local Institution
    Jan 11, 2022

    Advanced Melanoma Trial in Pittsburgh (Pembrolizumab Injection [Keytruda], Metformin)

    Recruiting
    • Advanced Melanoma
    • Pittsburgh, Pennsylvania
      Univ of Pittsburgh Medical Center Hillman Cancer Center
    Jan 24, 2022

    Melanoma, Stage II, HER2-positive, Advanced Melanoma Trial (RC48-ADC)

    Not yet recruiting
    • Melanoma, Stage II
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Efficacy of Prolgolimab in Advanced Melanoma in Routine Clinical

    Recruiting
    • Advanced Melanoma
      • Moscow, Russian Federation
        N.N. Blokhin National Medical Research Center of Oncology
      Nov 3, 2021

      Advanced Melanoma, Renal Cell Carcinoma Trial in New Haven (Nivolumab, Ipilimumab, APX005M)

      Recruiting
      • Advanced Melanoma
      • Renal Cell Carcinoma
      • New Haven, Connecticut
      • +1 more
      Nov 2, 2021

      Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston

      Recruiting
      • Advanced Endometrial Carcinoma
      • +36 more
      • Glutaminase Inhibitor IPN60090
      • Pembrolizumab
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 9, 2021

      Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)

      Recruiting
      • Advanced Melanoma
      • Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
      • Basel, Switzerland
        Division of Medical Oncology and Cancer Immunology, University H
      Aug 3, 2021

      Advanced Melanoma, Advanced Urothelial Carcinoma Trial in Beijing (TWP-101)

      Recruiting
      • Advanced Melanoma
      • Advanced Urothelial Carcinoma
      • Beijing, Beijing, China
        Peking University Cancer Hospital
      Jul 20, 2021

      Metastatic Melanoma, Advanced Melanoma, Metastatic Melanoma Stratified by MHC-II Expression Trial in Nashville (Nivolumab,

      Terminated
      Has Results
      • Metastatic Melanoma
      • +2 more
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Mar 26, 2021

      Advanced Melanoma, Triple-Negative Breast Cancer Trial in United States (Imprime PGG, Pembrolizumab)

      Completed
      • Advanced Melanoma
      • Triple-Negative Breast Cancer
      • Avondale, Arizona
      • +9 more
      Mar 23, 2021

      Response in Advanced or Metastatic Malignant Melanoma

      Completed
      • Advanced Melanoma
      • Metastatic Melanoma
        • Cork, Ireland
        • +5 more
        Nov 16, 2020

        Advanced Melanoma, Metastatic Melanoma Trial in China (humanized anti-PD-1 mAb toripalimab)

        Unknown status
        • Advanced Melanoma
        • Metastatic Melanoma
        • humanized anti-PD-1 monoclonal antibody toripalimab
        • Beijing, Beijing, China
        • +5 more
        Sep 28, 2020

        Advanced Melanoma Trial in Boston (pembrolizumab)

        Terminated
        Has Results
        • Advanced Melanoma
        • pembrolizumab
        • Boston, Massachusetts
        • +1 more
        Jun 29, 2020

        Melanoma, Advanced Melanoma Trial in Philadelphia (Gleevec + Temozolomide)

        Terminated
        • Melanoma
        • Advanced Melanoma
        • Gleevec + Temozolomide
        • Philadelphia, Pennsylvania
          Abramson Cancer Center at University of Pennsylvania
        Apr 6, 2020

        Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)

        Completed
        Has Results
        • Advanced Melanoma
        • Metastatic Melanoma
        • Los Angeles, California
        • +13 more
        Nov 14, 2019

        Advanced Melanoma Trial in Japan (Combination of GEN0101 and Pembrolizmub)

        Unknown status
        • Advanced Melanoma
        • Combination of GEN0101 and Pembrolizmub
        • Nagoya, Aichi, Japan
        • +6 more
        Jan 27, 2019

        Advanced Melanoma, Cancer Trial in Houston (Tesetaxel)

        Completed
        Has Results
        • Advanced Melanoma
        • Cancer
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Jul 16, 2018

        Advanced Melanoma Trial in Dallas (Vigil™ Vaccine)

        Terminated
        Has Results
        • Advanced Melanoma
        • Vigil™ Vaccine
        • Dallas, Texas
          Mary Crowley Cancer Research Centers
        May 21, 2018

        Advanced Melanoma Trial in Beijing (Apatinib, Temozolomide)

        Unknown status
        • Advanced Melanoma
        • Beijing, China
          Beijing Cancer Hospital
        Jan 30, 2018

        The Oncopanel Pilot (TOP) Study

        Completed
        • Colorectal Cancer Metastatic
        • +4 more
          • Abbotsford, British Columbia, Canada
          • +4 more
          Apr 13, 2017

          Malignant Solid Tumour, Ovarian Cancer, Triple Negative Breast Cancer Trial in London, Newcastle Upon Tyne and Wear (E7449

          Completed
          • Malignant Solid Tumour
          • +4 more
          • E7449 alone
          • +2 more
          • London, United Kingdom
          • +1 more
          Nov 15, 2016

          YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey

          Completed
          • Advanced Melanoma
          • Princeton, New Jersey
          • +1 more
          Dec 18, 2015

          Metastatic Melanoma, Malignant Metastatic Melanoma, Advanced Melanoma Trial in New York (MORAb-028)

          Terminated
          • Metastatic Melanoma
          • +3 more
          • New York, New York
            Memorial Sloan-Kettering Cancer Center
          Jul 15, 2014